Bisphosphonates
- 13 February 1998
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (2) , 263-269
- https://doi.org/10.1016/s0959-8049(97)10136-8
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorptionEndocrinology, 1996
- Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin.Journal of Clinical Investigation, 1995
- Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronateBritish Journal of Cancer, 1993
- Bone metastases and tumor-induced hypercalcemiaCurrent Opinion in Oncology, 1992
- Urinary pyridinium cross-links as markers of bone resorption in tumor- associated hypercalcemiaJournal of Clinical Endocrinology & Metabolism, 1992
- Parathyroid Hormone-Related Protein: Elevated Levels in both Humoral Hypercalcemia of Malignancy and Hypercalcemia Complicating Metastatic Breast Cancer*Journal of Clinical Endocrinology & Metabolism, 1991
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.Journal of Clinical Investigation, 1991
- Treatment of Hypercalcemia of Malignancy With Intravenous EtidronateArchives of internal medicine (1960), 1991
- Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-mediated Bone Resorption In VitroJournal of Clinical Investigation, 1982
- Quantitative Bone Histomorphometry in Humoral Hypercalcemia of Malignancy: Uncoupling of Bone Cell Activity*Journal of Clinical Endocrinology & Metabolism, 1982